Last reviewed · How we verify
quinacrine dihydrochloride - Escalation dose — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
quinacrine dihydrochloride - Escalation dose (quinacrine dihydrochloride - Escalation dose) — Neelesh Sharma MD PhD.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| quinacrine dihydrochloride - Escalation dose TARGET | quinacrine dihydrochloride - Escalation dose | Neelesh Sharma MD PhD | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- quinacrine dihydrochloride - Escalation dose CI watch — RSS
- quinacrine dihydrochloride - Escalation dose CI watch — Atom
- quinacrine dihydrochloride - Escalation dose CI watch — JSON
- quinacrine dihydrochloride - Escalation dose alone — RSS
Cite this brief
Drug Landscape (2026). quinacrine dihydrochloride - Escalation dose — Competitive Intelligence Brief. https://druglandscape.com/ci/quinacrine-dihydrochloride-escalation-dose. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab